1
|
Du X, Sonawane V, Zhang B, Wang C, de Ruijter B, Dömling ASS, Reiling N, Groves MR. Inhibitors of Aspartate Transcarbamoylase Inhibit Mycobacterium tuberculosis Growth. ChemMedChem 2023; 18:e202300279. [PMID: 37294060 DOI: 10.1002/cmdc.202300279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2023] [Revised: 06/07/2023] [Accepted: 06/07/2023] [Indexed: 06/10/2023]
Abstract
Aspartate transcarbamoylase (ATCase) plays a key role in the second step of de novo pyrimidine biosynthesis in eukaryotes and has been proposed to be a target to suppress cell proliferation in E. coli, human cells and the malarial parasite. We hypothesized that a library of ATCase inhibitors developed for malarial ATCase (PfATCase) may also contain inhibitors of the tubercular ATCase and provide a similar inhibition of cellular proliferation. Of the 70 compounds screened, 10 showed single-digit micromolar inhibition in an in vitro activity assay and were tested for their effect on M. tuberculosis cell growth in culture. The most promising compound demonstrated a MIC90 of 4 μM. A model of MtbATCase was generated using the experimental coordinates of PfATCase. In silico docking experiments showed this compound can occupy a similar allosteric pocket on MtbATCase to that seen on PfATCase, explaining the observed species selectivity seen for this compound series.
Collapse
Affiliation(s)
- Xiaochen Du
- XB20 Drug Design, Groningen Research Institute of Pharmacy, University of Groningen, A. Deusinglaan 1, Groningen, 9700AV (The, Netherlands
| | - Vidhisha Sonawane
- CATRIN, Department of Innovative Chemistry, PalackȳUniversity, 779 00, Olomouc - Holice, Czech Republic
| | - Bidong Zhang
- XB20 Drug Design, Groningen Research Institute of Pharmacy, University of Groningen, A. Deusinglaan 1, Groningen, 9700AV (The, Netherlands
| | - Chao Wang
- XB20 Drug Design, Groningen Research Institute of Pharmacy, University of Groningen, A. Deusinglaan 1, Groningen, 9700AV (The, Netherlands
| | - Bram de Ruijter
- XB20 Drug Design, Groningen Research Institute of Pharmacy, University of Groningen, A. Deusinglaan 1, Groningen, 9700AV (The, Netherlands
| | - Alexander S S Dömling
- XB20 Drug Design, Groningen Research Institute of Pharmacy, University of Groningen, A. Deusinglaan 1, Groningen, 9700AV (The, Netherlands
- CATRIN, Department of Innovative Chemistry, PalackȳUniversity, 779 00, Olomouc - Holice, Czech Republic
| | - Norbert Reiling
- RG Microbial Interface Biology, Research Center Borstel Leibniz Lung Center, Parkallee 1-40, Borstel, 23845, Sülfeld, Germany
- German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems Borstel, 23845, Greifswald, Germany
| | - Matthew R Groves
- XB20 Drug Design, Groningen Research Institute of Pharmacy, University of Groningen, A. Deusinglaan 1, Groningen, 9700AV (The, Netherlands
| |
Collapse
|
2
|
Wang R, Zhou X, Chen J, Chen Y, Xiong Y, Duan X, Liao X, Wang J. Ruthenium polypyridine complexes containing prenyl groups as antibacterial agents against Staphylococcus aureus through a membrane-disruption mechanism. Arch Pharm (Weinheim) 2023; 356:e2300175. [PMID: 37421212 DOI: 10.1002/ardp.202300175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2023] [Revised: 06/15/2023] [Accepted: 06/16/2023] [Indexed: 07/10/2023]
Abstract
Four new ruthenium polypyridyl complexes with prenyl groups, [Ru(bpy)2 (MHIP)](PF6 )2 (Ru(II)-1), [Ru(dtb)2 (MHIP)](PF6 )2 (Ru(II)-2), [Ru(dmb)2 (MHIP)](PF6 )2 (Ru(II)-3), and [Ru(dmob)2 (MHIP)](PF6 )2 (Ru(II)-4) (bpy = 2,2'-bipyridine, dtb = 4,4'-di-tert-butyl-2,2'-bipyridine, dmb = 4,4'-dimethyl-2,2'-bipyridine, dmob = 4,4'-dimethoxy-2,2'-bipyridine, and MHIP = 2-(2,6-dimethylhepta-1,5-dien-1-yl)-1H-imidazo[4,f][1,10]phenanthroline), were synthesized and characterized. Their antibacterial activities against Staphylococcus aureus were assessed, and the minimum inhibition concentration (MIC) value of Ru(II)-2 against S. aureus was only 0.5 µg/mL, showing the best antibacterial activity among them. S. aureus could be quickly killed by Ru(II)-2 in 30 min and Ru(II)-2 displayed an obvious inhibitive effect on the formation of a biofilm, which was essential to avoid the development of drug-resistance. Meanwhile, Ru(II)-2 exhibited a stable MIC value against antibiotic-resistant bacteria. The antibacterial mechanism of Ru(II)-2 was probably related to depolarization of the cell membrane, and a change of permeability was associated with the formation of reactive oxygen species, leading to leakage of nucleic acid and bacterial death. Furthermore, Ru(II)-2 hardly showed toxicity to mammalian cells and the Galleria mellonella worm. Finally, murine infection studies also illustrated that Ru(II)-2 was highly effective against S. aureus in vivo.
Collapse
Affiliation(s)
- Runbin Wang
- School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China
| | - Xiaomin Zhou
- Shenzhen Second People's Hospital, Shenzhen, China
| | - Jingjing Chen
- School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China
| | - Yushou Chen
- School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China
| | - Yanshi Xiong
- School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China
| | - Xuemin Duan
- School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China
| | - Xiangwen Liao
- School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China
| | - Jintao Wang
- School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China
| |
Collapse
|
3
|
Conversion of Glucose to 5-Hydroxymethylfurfural Using Consortium Catalyst in a Biphasic System and Mechanistic Insights. Catalysts 2023. [DOI: 10.3390/catal13030574] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/14/2023] Open
Abstract
We found an effective catalytic consortium capable of converting glucose to 5-hydroxymethylfurfural (HMF) in high yields (50%). The reaction consists of a consortium of a Lewis acid (NbCl5) and a Brønsted acid (p-sulfonic acid calix[4]arene (CX4SO3H)), in a microwave-assisted reactor and in a biphasic system. The best result for the conversion of glucose to HMF (yield of 50%) was obtained with CX4SO3H/NbCl5 (5 wt%/7.5 wt%), using water/NaCl and MIBK (1:3), at 150 °C, for 17.5 min. The consortium catalyst recycling was tested, allowing its reuse for up to seven times, while maintaining the HMF yield constant. Additionally, it proposed a catalytic cycle by converting glucose to HMF, highlighting the following two key points: the isomerization of glucose into fructose, in the presence of Lewis acid (NbCl5), and the conversion of fructose into HMF, in the presence of CX4SO3H/NbCl5. A mechanism for the conversion of glucose to HMF was proposed and validated.
Collapse
|
4
|
Gautam S, Qureshi KA, Jameel Pasha SB, Dhanasekaran S, Aspatwar A, Parkkila S, Alanazi S, Atiya A, Khan MMU, Venugopal D. Medicinal Plants as Therapeutic Alternatives to Combat Mycobacterium tuberculosis: A Comprehensive Review. Antibiotics (Basel) 2023; 12:antibiotics12030541. [PMID: 36978408 PMCID: PMC10044459 DOI: 10.3390/antibiotics12030541] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2023] [Revised: 03/05/2023] [Accepted: 03/06/2023] [Indexed: 03/11/2023] Open
Abstract
Tuberculosis (TB) is a serious infectious disease caused by Mycobacterium tuberculosis (MTB) and a significant health concern worldwide. The main threat to the elimination of TB is the development of resistance by MTB to the currently used antibiotics and more extended treatment methods, which is a massive burden on the health care system. As a result, there is an urgent need to identify new, effective therapeutic strategies with fewer adverse effects. The traditional medicines found in South Asia and Africa have a reservoir of medicinal plants and plant-based compounds that are considered another reliable option for human beings to treat various diseases. Abundant research is available for the biotherapeutic potential of naturally occurring compounds in various diseases but has been lagging in the area of TB. Plant-based compounds, or phytoproducts, are being investigated as potential anti-mycobacterial agents by reducing bacterial burden or modulating the immune system, thereby minimizing adverse effects. The efficacy of these phytochemicals has been evaluated through drug delivery using nanoformulations. This review aims to emphasize the value of anti-TB compounds derived from plants and provide a summary of current research on phytochemicals with potential anti-mycobacterial activity against MTB. This article aims to inform readers about the numerous potential herbal treatment options available for combatting TB.
Collapse
Affiliation(s)
- Silvi Gautam
- Department of Microbiology, Graphic Era Deemed to be University, Dehradun 248002, India
| | - Kamal A. Qureshi
- Department of Pharmaceutics, Unaizah College of Pharmacy, Qassim University, Unaizah 51911, Saudi Arabia
- Correspondence: (K.A.Q.); (D.V.)
| | | | - Sugapriya Dhanasekaran
- Department of Molecular Analytics, Institute of Bioinformatics, SSE-SIMATS, Chennai 602105, India
| | - Ashok Aspatwar
- Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland
| | - Seppo Parkkila
- Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland
- Fimlab Ltd., Tampere University Hospital, 33520 Tampere, Finland
| | - Samyah Alanazi
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11362, Saudi Arabia
| | - Akhtar Atiya
- Department of Pharmacognosy, College of Pharmacy, King Khalid University (KKU), Guraiger, Abha 62529, Saudi Arabia
| | - Mohd Masih Uzzaman Khan
- Department of Pharmaceutical Chemistry and Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Unaizah 51911, Saudi Arabia
| | - Divya Venugopal
- Department of Microbiology, Graphic Era Deemed to be University, Dehradun 248002, India
- Correspondence: (K.A.Q.); (D.V.)
| |
Collapse
|
5
|
Leitao RCF, Silva F, Ribeiro GH, Santos IC, Guerreiro JF, Mendes F, Batista AA, Pavan FR, da S Maia PI, Paulo A, Deflon VM. Gallium and indium complexes with isoniazid-derived ligands: Interaction with biomolecules and biological activity against cancer cells and Mycobacterium tuberculosis. J Inorg Biochem 2023; 240:112091. [PMID: 36527994 DOI: 10.1016/j.jinorgbio.2022.112091] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2022] [Revised: 12/01/2022] [Accepted: 12/02/2022] [Indexed: 12/12/2022]
Abstract
Gallium and indium octahedral complexes with isoniazid derivative ligands were successfully prepared. The ligands, isonicotinoyl benzoylacetone (H2L1) and 4-chlorobenzoylacetone isonicotinoyl hydrazone (H2L2), and their respective coordination compounds with gallium and indium [GaL1(HL1)] (GaL1), [GaL2(HL2)] (GaL2), [InL1(HL1)] (InL1) and [InL2(HL2)] (InL2) were investigated by NMR, ESI-MS, UV-Vis, IR, single-crystal X-ray diffraction and elemental analysis. In vitro interaction studies with human serum albumin (HSA) evidenced a moderate affinity of all complexes with HSA through spontaneous hydrophobic interactions. The greatest suppression of HSA fluorescence was caused by GaL2 and InL2, which was associated to the higher lipophilicity of H2L2. In vitro interaction studies with CT-DNA indicated weak interactions of the biomolecule with all complexes. Cytotoxicity assays with MCF-7 (breast carcinoma), PC-3 (prostate carcinoma) and RWPE-1 (healthy human prostate epithelial) cell lines showed that complexes with H2L2 are more active and selective against MCF-7, with the greatest cytotoxicity observed for InL2 (IC50 = 10.34 ± 1.69 μM). H2L1 and H2L2 were labelled with gallium-67, and it was verified that 67GaL2 has a greater lipophilicity than 67GaL1, as well as higher stability in human serum or in the presence of apo-transferrin. Cellular uptake assays with 67GaL1 and 67GaL2 evidenced that the H2L2-containing radiocomplex has a higher accumulation in MCF-7 and PC-3 cells than the non-halogenated congener 67GaL1. The anti-Mycobacterium tuberculosis assays revealed that both ligands and metal complexes are potent growth inhibitors, with MIC90 (μg mL-1) values observed from 0.419 ± 0.05 to 1.378 ± 0.21.
Collapse
Affiliation(s)
- Renan C F Leitao
- Instituto de Química de São Carlos, Universidade de São Paulo, 13566-590 São Carlos, SP, Brazil
| | - Francisco Silva
- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, 2695-066 Bobadela LRS, Portugal
| | - Gabriel H Ribeiro
- Departamento de Química, Universidade Federal de São Carlos, 13565-905 São Carlos, SP, Brazil
| | - Isabel C Santos
- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, 2695-066 Bobadela LRS, Portugal; Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, 1749-016 Lisboa, Portugal
| | - Joana F Guerreiro
- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, 2695-066 Bobadela LRS, Portugal
| | - Filipa Mendes
- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, 2695-066 Bobadela LRS, Portugal; Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, 1749-016 Lisboa, Portugal
| | - Alzir A Batista
- Departamento de Química, Universidade Federal de São Carlos, 13565-905 São Carlos, SP, Brazil
| | - Fernando R Pavan
- Faculdade de Ciências Farmacêuticas, UNESP - Universidade Estadual Paulista, Campus Araraquara, 14.800-903 Araraquara, SP, Brazil
| | - Pedro Ivo da S Maia
- Departamento de Química, Universidade Federal do Triângulo Mineiro, 38025-440 Uberaba, MG, Brazil
| | - António Paulo
- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, 2695-066 Bobadela LRS, Portugal; Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, 1749-016 Lisboa, Portugal
| | - Victor M Deflon
- Instituto de Química de São Carlos, Universidade de São Paulo, 13566-590 São Carlos, SP, Brazil.
| |
Collapse
|
6
|
Souza WA, Demarqui FM, de Almeida AM, Silva RTC, Alves DA, Araújo TG, Resende JALC, Pavan FR, Santos HFD, de Almeida MV, Guerra W. Synthesis and in vitro evaluation of antimycobacterial activity of two palladium(II) complexes based on 5-alkyl-1,3,4-oxadiazol-2(3H)-thione derivatives. J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2022.133888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
7
|
Do bioactive 8-hydroxyquinolines oxidovanadium(IV) and (V) complexes inhibit the growth of M. smegmatis? J Inorg Biochem 2022; 237:111984. [PMID: 36152468 DOI: 10.1016/j.jinorgbio.2022.111984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2022] [Revised: 08/22/2022] [Accepted: 08/25/2022] [Indexed: 01/18/2023]
Abstract
The antiproliferative effects of four series of VIVO- and VVO-based compounds containing 8-hydroxyquinoline ligands on the bacterium Mycolicibacterium smegmatis (M. smeg) were investigated. The effects on M. smeg were compared to the antiproliferative effects on the protozoan parasite Trypanosoma cruzi (T. cruzi), the causative agent for Chagas disease. In this study, we investigate the speciation of these compounds under physiological conditions as well as the antiproliferative effects on the bacterium M. smeg. We find that the complexes are more stable the less H2O is present, and that the stability increases in lipid-like environments. Only one heteroleptic complex and two homoleptic complexes were found to show similar antiproliferative effects on M. smeg as reported for T. cruzi so the responses generally observed by M.smeg. is less than observed by the pathogen. In summary, we find that M. smeg is more sensitive to the detailed structure of the V-complex but overall these complexes are less effective against M. smeg compared to T. cruzi.
Collapse
|
8
|
Amini M, Abdel-Jalil R, Moghadam ES, Al-Sadi AM, Talebi M, Amanlou M, Shongwe M. Piperazine-based Semicarbazone Derivatives as Potent Urease Inhibitors:
Design, Synthesis, and Bioactivity Screening. LETT DRUG DES DISCOV 2022. [DOI: 10.2174/1570180819666220405234009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:
An enzyme called urease assists highly pathogenic bacteria in colonizing and
maintaining themselves. Accordingly, inhibiting urease enzymes has been shown to be a promising strategy
for preventing ureolytic bacterial infections.
Objective:
This study aimed to synthesize and evaluate the bioactivity of a series of semicarbazone derivatives.
Methods:
A series of piperazine-based semicarbazone derivatives 5a-o were synthesized and isolated, and
their structures were elucidated by 1H-NMR and 13C-NMR spectroscopic techniques besides MS and
elemental analysis. The urease inhibition activity of these compounds was evaluated using the standard
urease enzyme inhibition kit. An MTT assay was performed on two different cell lines (NIH-3T3 and
MCF-7) to investigate the cytotoxicity profile.
Results:
All semicarbazone 5a-o exhibited higher urease inhibition activity (3.95–6.62 μM) than the reference
standards thiourea and hydroxyurea (IC50: 22 and 100 μM, respectively). Derivatives 5m and 5o
exhibited the best activity with the IC50 values of 3.95 and 4.05 μM, respectively. Investigating the cytotoxicity
profile of the target compound showed that all compounds 5a-o have IC50 values higher than 50
μM for both tested cell lines.
Conclusion:
The results showed that semicarbazone derivatives could be highly effective as urease inhibitors.
Collapse
Affiliation(s)
- Mohsen Amini
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical
Sciences, Tehran 1417614411, Iran
- Drug Design and Development Research Center, The Institute of Pharmaceutical
Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
| | - Raid Abdel-Jalil
- Department of Chemistry, College of Science, Sultan Qaboos University, Al-Khod 123, Muscat, Sultanate of Oman
| | - Ebrahim Saeedian Moghadam
- Department of Chemistry, College of Science, Sultan Qaboos University, Al-Khod 123, Muscat, Sultanate of Oman
| | - Abdullah Mohammed Al-Sadi
- Department of Crop Sciences, College of Agricultural and Marine Sciences, Sultan Qaboos University, Al-Khod 123,
Muscat, Sultanate of Oman
| | - Meysam Talebi
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical
Sciences, Tehran 1417614411, Iran
| | - Massoud Amanlou
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical
Sciences, Tehran 1417614411, Iran
- Drug Design and Development Research Center, The Institute of Pharmaceutical
Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
| | - Musa Shongwe
- Department of Chemistry, College of Science, Sultan Qaboos University, Al-Khod 123, Muscat, Sultanate of Oman
| |
Collapse
|
9
|
Alfonso‐Herrera LA, Rosete‐Luna S, Hernández‐Romero D, Rivera‐Villanueva JM, Olivares‐Romero JL, Cruz‐Navarro JA, Soto‐Contreras A, Arenaza‐Corona A, Morales‐Morales D, Colorado‐Peralta R. Transition Metal Complexes with Tridentate Schiff Bases (O N O and O N N) Derived from Salicylaldehyde: An Analysis of Their Potential Anticancer Activity. ChemMedChem 2022; 17:e202200367. [PMID: 36068174 PMCID: PMC9826236 DOI: 10.1002/cmdc.202200367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Revised: 09/05/2022] [Indexed: 01/11/2023]
Abstract
Although it is known that the first case of cancer was recorded in ancient Egypt around 1600 BC, it was not until 1917 during the First World War and the development of mustard gas that chemotherapy against cancer became relevant; however, its properties were not recognised until 1946 to later be used in patients. In this sense, the use of metallopharmaceuticals in cancer therapy was extensively explored until the 1960s with the discovery of cisplatin and its anticancer activity. From that date to the present, the search for more effective, more selective metallodrugs with fewer side effects has been an area of continuous exploration. Efforts have led to considering a wide variety of metals from the periodic table, mainly from the d-block, as well as a wide variety of organic ligands, preferably with proven biological activity. In this sense, various research groups have found an ideal binder in Schiff bases, since their raw materials are easily accessible, their synthesis conditions are friendly and their denticity can be manipulated. Therefore, in this review, we have explored the anticancer and antitumor activity reported in the literature for coordination complexes of d-block metals coordinated with tridentate Schiff bases (O N O and O N N) derived from salicylaldehyde. For this work, we have used the main scientific databases CCDC® and SciFinder®.
Collapse
Affiliation(s)
- Luis A. Alfonso‐Herrera
- Universidad Veracruzana Facultad de Ciencias QuímicasProlongación de Oriente 6, No. 100994340, OrizabaVeracruzMéxico
- Universidad Autónoma de Nuevo León Facultad de Ingeniería Civil Departamento de Ecomateriales y Energía Av. Universidad S/N Ciudad Universitaria64455San Nicolás de los GarzaNuevo LeónMéxico
| | - Sharon Rosete‐Luna
- Universidad Veracruzana Facultad de Ciencias QuímicasProlongación de Oriente 6, No. 100994340, OrizabaVeracruzMéxico
| | - Delia Hernández‐Romero
- Universidad Veracruzana Facultad de Ciencias QuímicasProlongación de Oriente 6, No. 100994340, OrizabaVeracruzMéxico
| | - José M. Rivera‐Villanueva
- Universidad Veracruzana Facultad de Ciencias QuímicasProlongación de Oriente 6, No. 100994340, OrizabaVeracruzMéxico
| | - José L. Olivares‐Romero
- Instituto de Ecología A.C. Red de Estudios Moleculares AvanzadosClúster Científico y Tecnológico BioMimic® Carretera Antigua a Coatepec, No. 35191070Xalapa, VeracruzMéxico
| | - J. Antonio Cruz‐Navarro
- Universidad Veracruzana Facultad de Ciencias QuímicasProlongación de Oriente 6, No. 100994340, OrizabaVeracruzMéxico
- Universidad Autónoma del Estado de HidalgoÁrea Académica de Química Km 4.5 Carretera Pachuca-Tulancingo42184, Mineral de la ReformaHidalgoMéxico
| | - Anell Soto‐Contreras
- Universidad Veracruzana Facultad de Ciencias QuímicasProlongación de Oriente 6, No. 100994340, OrizabaVeracruzMéxico
- Universidad VeracruzanaFacultad de Ciencias Biológicas y Agropecuarias Km 177 Camino Peñuela-Amatlán S/N94500, Peñuela, Amatlán de los ReyesVeracruzMéxico
| | - Antonino Arenaza‐Corona
- Universidad Nacional Autónoma de México Instituto de Química, Circuito Exterior S/N04510Ciudad de MéxicoMéxico
| | - David Morales‐Morales
- Universidad Nacional Autónoma de México Instituto de Química, Circuito Exterior S/N04510Ciudad de MéxicoMéxico
| | - Raúl Colorado‐Peralta
- Universidad Veracruzana Facultad de Ciencias QuímicasProlongación de Oriente 6, No. 100994340, OrizabaVeracruzMéxico
| |
Collapse
|
10
|
Shuvalov VY, Rozhkova YS, Plekhanova IV, Kostyuchenko AS, Shklyaev YV, Fisyuk AS. Synthesis of 3-Amino-6,7-Dihydroferroceno[a]Quinolizin-4-One Derivatives via the Reaction of 3,4-Dihydroferroceno[c]Pyridines with Azlactones. Chem Heterocycl Compd (N Y) 2022. [DOI: 10.1007/s10593-022-03050-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
11
|
Scarim CB, Pavan FR. Recent advancement in drug development of nitro(NO 2 )-heterocyclic compounds as lead scaffolds for the treatment of Mycobacterium tuberculosis. Drug Dev Res 2022; 83:842-858. [PMID: 35106801 DOI: 10.1002/ddr.21921] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2021] [Revised: 12/26/2021] [Accepted: 01/13/2022] [Indexed: 11/11/2022]
Abstract
Tuberculosis (TB) is an infectious disease caused predominantly by Mycobacterium tuberculosis (Mtb). It was responsible for approximately 1.4 million deaths worldwide in 2019. The lack of new drugs to treat drug-resistant strains is a principal factor for the slow rise in TB infections. Our aim is to aid the development of new TB treatments by describing improvements (last decade, 2011-2021) to nitro(NO2 )-based compounds that have shown activity or pharmacological properties (e.g., anti-proliferative, anti-kinetoplastid) against Mtb. For all compounds, we have included final correlations of minimum inhibitory concentrations against Mtb (H37 Rv).
Collapse
Affiliation(s)
- Cauê Benito Scarim
- Department of Cell and Molecular Biology, University of Mississippi Medical Center (UMMC), Jackson, Mississippi, USA
| | - Fernando Rogério Pavan
- School of Pharmaceutical Sciences, Sao Paulo State University (UNESP), Araraquara, Sao Paulo, Brazil
| |
Collapse
|
12
|
Chen Y, Liu L, Wang X, Liao Z, Wang R, Xiong YS, Chen J, jiang G, Wang J, Liao X. Synthesis and antibacterial activity study of ruthenium-based metallodrugs with membrane-disruptive mechanism against Staphylococcus aureus. Dalton Trans 2022; 51:14980-14992. [DOI: 10.1039/d2dt01531e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The wide spread of drug-resistant bacteria, especially methicillin-resistant Staphylococcus aureus (MRSA), have posed a tremendous threat to global health. Of particular concern, resistance to vancomycin, linezolid and daptomycin have already...
Collapse
|
13
|
Goudarzi A, Ghassemzadeh M, Saeidifar M, Aghapoor K, Mohsenzadeh F, Neumüller B. In vitro cytotoxicity and antibacterial activity of [Pd(AMTTO)(PPh 3) 2]: a novel promising palladium( ii) complex. NEW J CHEM 2022. [DOI: 10.1039/d1nj05545c] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
The synthesis and characterization of a novel palladium complex based on a bioactive 3-mercapto-1,2,4-triazine derivative have been investigated. The Pd(ii) complex showed excellent anticancer and antibacterial activity.
Collapse
Affiliation(s)
- Atousa Goudarzi
- Department of Inorganic Chemistry, Chemistry & Chemical Engineering Research Center of Iran, Pajoohesh Blvd., 17th Km of Tehran–Karaj Highway, Tehran 14968-13151, Iran
| | - Mitra Ghassemzadeh
- Department of Inorganic Chemistry, Chemistry & Chemical Engineering Research Center of Iran, Pajoohesh Blvd., 17th Km of Tehran–Karaj Highway, Tehran 14968-13151, Iran
| | - Maryam Saeidifar
- Department of Nanotechnology and Advanced Materials, Materials and Energy Research Center, Karaj, Iran
| | - Kioumars Aghapoor
- Department of Inorganic Chemistry, Chemistry & Chemical Engineering Research Center of Iran, Pajoohesh Blvd., 17th Km of Tehran–Karaj Highway, Tehran 14968-13151, Iran
| | - Farshid Mohsenzadeh
- Department of Inorganic Chemistry, Chemistry & Chemical Engineering Research Center of Iran, Pajoohesh Blvd., 17th Km of Tehran–Karaj Highway, Tehran 14968-13151, Iran
| | - Bernhard Neumüller
- Fachbereich Chemie, Philipps-Universität Marburg, Hans-Meerwein-Strasse, 35032 Marburg, Germany
| |
Collapse
|
14
|
Recent advancements and developments in search of anti-tuberculosis agents: A quinquennial update and future directions. J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2021.131473] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
15
|
New silver(I) phosphino complexes: Evaluation of their potential as prospective agents against Mycobacterium tuberculosis. J Inorg Biochem 2021; 227:111683. [PMID: 34896768 DOI: 10.1016/j.jinorgbio.2021.111683] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Revised: 11/19/2021] [Accepted: 11/28/2021] [Indexed: 12/23/2022]
Abstract
Despite being a preventable and curable disease, Tuberculosis (TB) is the world's top infectious killer. Development of new drugs is urgently needed. In this work, the synthesis and characterization of new silver(I) complexes, that include N'-[(E)-(pyridine-2-ylmethylene)pyrazine-2-carbohydrazide, HPCPH, as main ligand and substituted aryl-phosphines as auxiliary ligands, is reported. HPCPH was synthesized from pyrazinoic acid, the active metabolite of the first-line antimycobacterial drug pyrazinamide. Complexes [Ag(HPCPH)(PPh3)2]OTf (1), [Ag(HPCPH)((P(p-tolyl)3)2]OTf (2) and [Ag(HPCPH)(P(p-anisyl)3)2]OTf (3) were characterized in solid state and in solution by elemental analysis and FTIR and NMR spectroscopies (OTftriflate). Crystal structures of (1,2) were determined by XRD. The Ag atom is coordinated to azomethine and pyridine nitrogen atoms of HPCPH ligand and to the phosphorous atom of each aryl-phosphine co-ligand. Although HPCPH did not show activity, the Ag(I) compounds demonstrated activity against Mycobacterium tuberculosis (MTB), H37Rv strain, and multi-drug resistant clinical isolates (MDR-TB). Globally, results showed that the compounds are not only effective against the sensitive strain, but are more potent against MDR-TB than antimycobacterial drugs used in therapy. The compounds showed low to moderate selectivity index values (SI) towards the bacteria, using MRC-5 cells (ATCC CCL-171) as mammalian cell model. Interaction with DNA was explored to get insight into the potential mechanism of action against the pathogen. No significant interaction was detected, allowing to discard this biomolecule as a potential molecular target. Compound 1 was identified as a hit compound (MIC90 2.23 μM; SI 4.4) to develop further chemical modifications in the search for new drugs.
Collapse
|
16
|
Soleymani-Babadi S, Beheshti A, Nasiri E, Bahrani-Pour M, Motamedi H, Mayer P. Simple synthesis of novel magnetic silver polymer nanocomposites with a good separation capacity and intrinsic antibacterial activities with high performance. Dalton Trans 2021; 50:15538-15550. [PMID: 34651632 DOI: 10.1039/d1dt00176k] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Two new coordination polymers namely, [(AgCN)4LS]n (1) and [(AgCN)3LN]n (2), were successfully synthesized by the reaction of AgNO3 and cyanide as a co-anion with LS[1,1'-(hexane-1,4-diyl)bis(3-methylimidazoline-2-thione] and LN[1,1,3,3-tetrakis(3,5-dimethyl-1-pyrazole)propane] ligands in order to use them for the preparation of magnetic nanocomposites with MnFe2O4 nanoparticles by an efficient and facile method. They were then well characterized via numerous techniques, including elemental analysis, FT-IR spectroscopy, TGA, PXRD, SEM, TEM, EDX, VSM, BET, ICP, and single-crystal X-ray diffraction. The considered polymers and their magnetic nanocomposites with nearly the same antibacterial activity demonstrated a highly inhibitive effect on the growth of Gram-negative (Escherichia coli, Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus, Bacillus subtilis) bacteria. By considering the simple separation and recyclable characters of the magnetic nanocomposites, these materials are suitable to be used in biological applications.
Collapse
Affiliation(s)
- Susan Soleymani-Babadi
- Department of Chemistry, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
| | - Azizolla Beheshti
- Department of Chemistry, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
| | - Elahe Nasiri
- Department of Chemistry, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
| | - Maryam Bahrani-Pour
- Department of Chemistry, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
| | - Hossein Motamedi
- Department of Biology, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran.,Biotechnology and Biological Science Research Center, Shahid Chamran University of Ahvaz, Ahvaz, Iran
| | - Peter Mayer
- LMU München Department Chemie Butenandtstr, 5-13, (D)81377 München, Germany
| |
Collapse
|
17
|
Scarim CB, de Farias RL, Chiba DE, Chin CM. Insight into Recent Drug Discoveries against Trypanosomatids and Plasmodium spp Parasites: New Metal-based Compounds. Curr Med Chem 2021; 29:2334-2381. [PMID: 34533436 DOI: 10.2174/0929867328666210917114912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2021] [Revised: 06/30/2021] [Accepted: 07/05/2021] [Indexed: 11/22/2022]
Abstract
Scaffolds of metal-based compounds can act as pharmacophore groups in several ligands to treat various diseases, including tropical infectious diseases (TID). In this review article, we investigate the contribution of these moieties to medicinal inorganic chemistry in the last seven years against TID, including American trypanosomiasis (Chagas disease), human African trypanosomiasis (HAT, sleeping sickness), leishmania, and malaria. The most potent metal-based complexes are displayed and highlighted in figures, tables and graphics; according to their pharmacological activities (IC50 > 10µM) against Trypanosomatids and Plasmodium spp parasites. We highlight the current progresses and viewpoints of these metal-based complexes, with a specific focus on drug discovery.
Collapse
Affiliation(s)
- Cauê Benito Scarim
- Sao Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara, SP, 14800-903, Brazil
| | - Renan Lira de Farias
- Sao Paulo State University (UNESP), Institute of Chemistry, 14800-060, Araraquara-SP, Brazil
| | - Diego Eidy Chiba
- Sao Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara, SP, 14800-903, Brazil
| | - Chung Man Chin
- Sao Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara, SP, 14800-903, Brazil
| |
Collapse
|